List view / Grid view

Multiple sclerosis

news

Genzyme receives positive CHMP opinion for LEMTRADA™ in Europe

28 June 2013 | By Sanofi

"Today’s CHMP opinions set the stage for the approval of two important new treatment options..."

news

Effect of Genzyme’s LEMTRADA maintained in patients beyond two-year pivotal MS studies

21 March 2013 | By Sanofi

Results from the first year of the extension study of LEMTRADA™ (alemtuzumab)...

news

Genzyme’s LEMTRADA™ application for MS accepted for review by the FDA

28 January 2013 | By Sanofi

Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.

news

Sanofi provides an update on its research & development pipeline

8 January 2013 | By Sanofi

Sanofi will provide an update on its Research & Development (R&D) pipeline...

news

Genzyme announces publication of LEMTRADA (alemtuzumab) pivotal studies in The Lancet

31 October 2012 | By

Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications...

news

Genzyme to present new data from AUBAGIO® and LEMTRADA(TM) Clinical Development Programs at ECTRIMS

9 October 2012 | By Genzyme

New data from Genzyme’s clinical development programs...

news

Genzyme submits applications to FDA and EMA for approval of LEMTRADA™ (alemtuzumab) for multiple sclerosis

12 June 2012 | By Sanofi

Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...

news

New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine

18 May 2012 | By Biogen Idec / Elan Corporation plc

Use of biomarker has potential to advance personalised treatment for MS patients...

news

Genzyme demonstrates depth of MS pipeline at AAN with results from Miltiple Sclerosis Phase III trials

20 April 2012 | By Sanofi

Full CARE-MS II results for Alemtuzumab to be unveiled...

RedHill Biopharma has last patient visit in phase IIa study with RHB-104 for multiple sclerosis

article

Discovery and validation of biomarkers for multiple sclerosis

13 December 2011 | By Ole Pless and Sheraz Gul, European ScreeningPort GmbH

Multiple Sclerosis (MS) is an autoimmune disease leading to a chronic inflammation and degeneration of the central nervous system. It is one of the major neurological diseases with approximately 2.5 million suffering patients worldwide. Until now, the underlying mechanisms have not been fully elucidated, but the cause of the disease…

news

Genzyme announces successful Phase III results for Alemtuzumab (LEMTRADA) in multiple sclerosis

14 November 2011 | By Sanofi

The Phase lll CARE-MS ll trial met both of its co-primary endpoints...

news

Alemtuzumab significantly reduces relapses in multiple sclerosis vs interferon beta-1a in a Phase III study

22 October 2011 | By Sanofi

New results from the CARE-MS I trial...

news

Oral BG-12 (Dimethyl Fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression

21 October 2011 | By Biogen Idec

Phase 3 clinical trial demonstrated significant clinical effects...

news

Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)

11 July 2011 | By Sanofi

Sanofi and Genzyme announced positive top-line results...

news

Sanofi-Aventis completes acquisition of Genzyme Corporation

8 April 2011 | By Sanofi-Aventis

Sanofi-aventis has announced that it has completed its acquisition of Genzyme Corporation...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Multiple sclerosis